Home › Urothelial (Transitional Cell) Carcinoma › Florida › Miami

Urothelial (Transitional Cell) Carcinoma clinical trials in Miami, FL

5 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

RecruitingPhase 1

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT06439836

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

RecruitingPhase 1

University of Miami, Miami

Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06293898

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

RecruitingPhase 1

Exelixis Clinical Site #47, Miami

Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT05176483

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study

Massive Bio SYNERGY-AI site, Miami

All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

RecruitingObservational study

Mount Sinai Medical Center of Florida, Inc., Miami

Ages 18 and older · All sexes · Updated Feb 28, 2025 · NCT05874921

Urothelial (Transitional Cell) Carcinoma trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.